Skip to main content

Table 2 clinical profile of patients on clozapine

From: Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India

Diagnosis No of patients (n)/percentage (%age)
Treatment-resistant schizophrenia 66 (75.0)
Treatment-resistant schizoaffective disorder 5 (5.7)
Treatment resistant bipolar disorder 5 (5.7)
Schizophrenia with suicidality 6 (6.8)
Tardive dyskinesia 3 (3.4)
Parkinsonism with psychotic features 1 (1.1)
Neuroacanthocytosis 1 (1.1)
Psychotic depression 1 (1.1)
Comorbidity
 None 81 (92.0)
 Hypothyroidism 4 (4.5)
 Hypertension 1 (1.1)
 Diabetes mellitus 1 (1.1)
 Parkinsonism 1(1.1)
No. of antipsychotics used prior to clozapine
 2 (two) 38 (43.2)
 > 2 (more than two) 50 (56.8)
Antipsychotic used prior to clozapine
 Haloperidol 66 (75)
 Chlorpromazine 2 (2.3)
 Olanzapine 65 (73.9)
 Risperidone 34 (38.6)
 Amisulpride 11 (12.5)
 Quetiapine 5 (5.7)
 Aripiprazole 4 (4.5)
 Paliperidone 1 (1.1)
Dose range of clozapine (in mgs)
 <= 100 mgs 5 (5.7)
 101–200 mgs 22 (25.0)
 201–300 mgs 21 (23.9)
 301–400 mgs 22 (25.0)
 401–500 mgs 11 (12.5)
 501–600 mgs 3 (3.4)
 > 600 mgs 4 (4.5)